[Thrombosis of the renal veins in a premature infant. Treatment with heparin and urokinase].
Jacotot
T
T
Roussel
B
B
Leroux
B
B
Potron
G
G
Droulle
C
C
Coffin
R
R
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003490:Cyanosis / Q000209:etiology; D003681:Dehydration / Q000150:complications; D003968:Diarrhea, Infantile / Q000150:complications; D004417:Dyspnea / Q000209:etiology; D005165:Factor V / Q000378:metabolism; D005167:Factor VII / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D010530:Peritoneal Dialysis; D010958:Plasminogen / Q000378:metabolism; D012082:Renal Veins; D015912:Thrombolytic Therapy / Q000379:methods; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy*
D000925:Anticoagulants; D005165:Factor V; D005167:Factor VII; D005170:Factor X; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator